List of Exhibits
Exhibit 1 Segmentation of US Point-of-care Diagnostics Market
Exhibit 2 Market Size Calculation Approach 2018
Exhibit 3 Diagnosis Steps Involved in Non-waived and CLIA-waived Diagnostic Testing
Exhibit 4 Advantages of Early Diagnosis and Prevention
Exhibit 5 Major POC Diagnostic Testing Limitations
Exhibit 6 Common Errors in POC Diagnostic Tests
Exhibit 7 US Point-of-care Diagnostics Market 2018–2024 ($ million)
Exhibit 8 Five Forces Analysis 2017
Exhibit 9 US Market by Product Type
Exhibit 10 US Market 2018 and 2024 (%)
Exhibit 11 US Point-of-care Diagnostics Market 2018−2024 ($ million)
Exhibit 12 US Market by POC Test Kits/Consumables 2018–2024 ($ million)
Exhibit 13 US Market by Analyzers/Instruments 2018–2024
Exhibit 14 US Market by Application Type
Exhibit 15 US Point-of-care Diagnostics Market by Application 2018 and 2024 (%)
Exhibit 16 US Market by Application 2018−2024 ($ million)
Exhibit 17 US Market by Blood Glucose Testing 2018–2024 ($ million)
Exhibit 18 US Market by Cardiometabolic Testing 2018–2024 ($ million)
Exhibit 19 US Market by Infectious Disease Testing 2018–2024 ($ million)
Exhibit 20 US Point-of-care Diagnostics Market by Blood Coagulation Testing 2018–2024 ($ million)
Exhibit 21 US Market by Hematology 2018–2024 ($ million)
Exhibit 22 US Market by Cancer Testing 2018–2024 ($ million)
Exhibit 23 US Point-of-care Diagnostics Market by Drugs of Abuse Testing 2018–2024 ($ million)
Exhibit 24 US Market by Pregnancy and Fertility/Ovulation Testing 2018–2024 ($ million)
Exhibit 25 US Market by End-user
Exhibit 26 US Market 2018 and 2024 (%)
Exhibit 27 US Point-of-care Diagnostics Market by End-user 2018−2024 ($ million)
Exhibit 28 US Market by Professional Healthcare Settings 2018 (%)
Exhibit 29 US Market by Professional Healthcare Settings 2018−2024 ($ million)
Exhibit 30 US Market by Professional Healthcare Settings 2018−2024 (%)
Exhibit 31 US Market by Professional Healthcare Settings 2018–2024 ($ million)
Exhibit 32 US Market by Hospitals and Laboratories 2018–2024 ($ million)
Exhibit 33 US Market by Ambulatory Care Settings 2018–2024 ($ million)
Exhibit 34 US Market by Emergency Care/Urgent Care Centers 2018–2024 ($ million)
Exhibit 35 US Market by Home Care 2018–2024 ($ million)
Exhibit 36 US Market by Other End-users 2018–2024 ($ million)
Exhibit 37 US Market by Usage Type
Exhibit 38 US Market by Usage Type 2018 & 2024 (%)
Exhibit 39 US Market by Usage Type 2018−2024 ($ million)
Exhibit 40 US Point-of-care Diagnostics Market by Usage Type 2018−2024 (%)
Exhibit 41 Prescription-based US Point-of-care Diagnostics Market 2018−2024 ($ million)
Exhibit 42 At-home/OTC-based US Point-of-care Diagnostics Market 2018−2024 ($ million)
Exhibit 43 Abbott Sales Breakdown by Segments 2017
Exhibit 44 F. Hoffmann-La Roche Sales Breakdown by Divisions 2017
Exhibit 45 Siemens Healthineers Revenue Breakdown by Business Segments 2017 (%)
Exhibit 46 Danaher Sales Breakdown by Business Segments 2017 (%)
Exhibit 47 Danaher Business Segments R&D Expenditure 2017 (%)
Exhibit 48 Quidel Revenue Breakdown by Product Categories 2017 (%)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2017
Table 3 Recent Product Approvals in US Point-of-care Diagnostics Market
Table 4 Tests Granted CLIA-waived Status by CMS and their CPT Codes Recently
Table 5 Few Popular Innovative POC Diagnostics Available in US
Table 6 YOY Impact of Market Growth Enablers 2018−2024
Table 7 YOY Impact of Market Growth Restraints 2018−2024
Table 8 Popular POC Molecular Diagnostics and Tests in US
Table 9 xPOCT Systems Available in US
Table 10 Recent Acquisitions in Point-of-care Diagnostics Market
Table 11 US Point-of-care Diagnostics Market: Pipeline Devices and Tests
Table 12 Microfluidic-based POC Devices Under Investigation
Table 13 YOY Impact of Market Opportunities & Trends 2018−2024
Table 14 Popular Blood Glucose Meter Brands in US
Table 15 US Point-of-care Diagnostics Market: Vendors Ranking
Table 16 Abbott: Product Offerings
Table 17 F. Hoffmann-La Roche: Product Offerings
Table 18 Siemens Healthineers: Product Offerings
Table 19 Danaher: Product Offerings
Table 20 LifeScan: Product Offerings
Table 21 Ascensia Diabetes Care: Product Offerings
Table 22 BD: Product Offerings
Table 23 Quidel: Product Offerings
Table 24 Abaxis: Product Offerings
Table 25 ACON Laboratories: Product Offerings
Table 26 AgaMatrix: Product Offerings
Table 27 Arbor Vita: Product Offerings
Table 28 bioMérieux: Product Offerings
Table 29 Chembio Diagnostic Systems: Product Offerings
Table 30 EKF Diagnostics: Product Offering
Table 31 Exact Sciences: Product Offerings
Table 32 Instrumentation Laboratory: Major Product Offerings
Table 33 Meridian Bioscience: Product Offerings
Table 34 Sekisui Diagnostics: Product Offerings
Table 35 Sinocare: Product Offerings
Table 36 Sysmex America: Product Offerings
Table 37 Swiss Precision Diagnostics: Product Offerings
Table 38 Trinity Biotech: Product Offerings
Table 39 Qualitative Summary of US Point-of-care Diagnostics Market
Table 40 US Market by Application 2018–2024
Table 41 US Market by Product Types 2018–2024
Table 42 US Market by Prescription Types 2018–2024
Table 43 US Point-of-care Diagnostics Market by End-user 2018–2024